Table 1 Clinicopathological features of RUGC patients included in this study
Age | 62 (38–88) |
|---|---|
Sex (male/female) | 59/19 |
ECOG PS (0 / 1 / 2 / 3) | 29 / 37 / 10 / 2 |
Disease status (unresectable / recurrence) | 41 / 37 |
Histology (differentiated / undifferentiated / unknown) | 45 / 31 /2 |
HER2 status (positive / negative / unknown) | 17 / 46 / 15 |
Number of previous treatments (2 / 3 / 4) | 65 / 8 / 5 |
Site of metastasis or recurrence | |
　Peritoneal metastasis | 41 |
　Lymph-node metastasis | 23 |
　Liver metastasis | 18 |
　Bone metastasis | 5 |
　Others | 11 |
Number of nivolumab treatments | 12 (3–40) |
irAEs (present / absent) | 15 / 63 |